These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 24497359)
1. Measuring interferon alpha and other cytokines in SLE. Olferiev M; Lliguicota M; Kirou KA; Crow MK Methods Mol Biol; 2014; 1134():131-50. PubMed ID: 24497359 [TBL] [Abstract][Full Text] [Related]
2. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221 [TBL] [Abstract][Full Text] [Related]
3. Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation. Becker-Merok A; Østli-Eilersten G; Lester S; Nossent J Lupus; 2013 Feb; 22(2):155-63. PubMed ID: 23213068 [TBL] [Abstract][Full Text] [Related]
4. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930 [TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population. Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083 [TBL] [Abstract][Full Text] [Related]
6. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Hermansen ML; Hummelshøj L; Lundsgaard D; Hornum L; Keller P; Fleckner J; Fox B; Poulsen LK; Jacobsen S Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117 [TBL] [Abstract][Full Text] [Related]
7. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023 [TBL] [Abstract][Full Text] [Related]
8. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus. Lin LH; Ling P; Liu MF J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682 [TBL] [Abstract][Full Text] [Related]
9. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. Batteux F; Palmer P; Daëron M; Weill B; Lebon P Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117 [TBL] [Abstract][Full Text] [Related]
10. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro. Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus. Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C Front Immunol; 2021; 12():688753. PubMed ID: 34276678 [TBL] [Abstract][Full Text] [Related]
12. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. Vallin H; Perers A; Alm GV; Rönnblom L J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325 [TBL] [Abstract][Full Text] [Related]
13. Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus. Li J; Fu Q; Cui H; Qu B; Pan W; Shen N; Bao C Arthritis Rheum; 2011 Feb; 63(2):492-502. PubMed ID: 21280004 [TBL] [Abstract][Full Text] [Related]
14. Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression. Liu TF; Jones BM; Wong RW; Srivastava G Cytokine; 1999 Oct; 11(10):805-11. PubMed ID: 10525320 [TBL] [Abstract][Full Text] [Related]
15. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830 [TBL] [Abstract][Full Text] [Related]
16. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472 [TBL] [Abstract][Full Text] [Related]
17. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. Båve U; Alm GV; Rönnblom L J Immunol; 2000 Sep; 165(6):3519-26. PubMed ID: 10975873 [TBL] [Abstract][Full Text] [Related]
18. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487 [TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of gene expression in lupus. Crow MK; Wohlgemuth J Arthritis Res Ther; 2003; 5(6):279-87. PubMed ID: 14680503 [TBL] [Abstract][Full Text] [Related]
20. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Bengtsson AA; Sturfelt G; Truedsson L; Blomberg J; Alm G; Vallin H; Rönnblom L Lupus; 2000; 9(9):664-71. PubMed ID: 11199920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]